TEVA PHARMACEUTICAL FINANCE CO B.V.

Related Filers (15)

Other (7)

EFFECT
Thursday, 4/19/2018
Notice of Effectiveness
CORRESP
Monday, 4/16/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
POSASR
Wednesday, 7/13/2016
Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
F-3ASR
Monday, 2/9/2015
Automatic shelf registration statement of securities of well-known seasoned issuers
F-3ASR
Friday, 12/9/2011
Automatic shelf registration statement of securities of well-known seasoned issuers
POSASR
Friday, 8/26/2011
Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
F-3ASR
Tuesday, 12/20/2005
Automatic shelf registration statement of securities of well-known seasoned issuers
Show More

Prospectus (13)

S-3/A
Wednesday, 3/28/2018
Registration statement for specified transactions by certain issuers
S-3/A
Friday, 2/16/2018
Registration statement for specified transactions by certain issuers
S-3
Monday, 1/29/2018
Registration statement for specified transactions by certain issuers
FWP
Friday, 12/14/2012
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B5
Friday, 12/14/2012
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Thursday, 12/13/2012
Prospectus filed pursuant to Rule 424(b)(5)
FWP
Tuesday, 11/8/2011
Filing under Securities Act Rules 163/433 of free writing prospectuses
FWP
Tuesday, 11/8/2011
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B5
Tuesday, 11/8/2011
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Monday, 11/7/2011
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Monday, 1/30/2006
Prospectus filed pursuant to Rule 424(b)(5)
FWP
Friday, 1/27/2006
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B5
Thursday, 1/26/2006
Prospectus filed pursuant to Rule 424(b)(5)
Show More